Eli Lilly CEO David Ricks On Alzheimer’s Disease Drugs
CNBC transcript: Eli Lilly And Co (NYSE:LLY) Chairman & CEO David Ricks speaks with Meg Tirrell live during CNBC’s Healthy Returns Summit today Q1 2021 hedge fund letters, conferences and more WHEN: Today, Tuesday, May 11 WHERE: CNBC’s “Healthy Returns Summit: New Era of Innovation” CNBC's Interview With Eli Lilly CEO David RicksTYLER MATHISEN: More than six million Americans have Alzheimer's disease, and that number predicted to escalate more than double by 2015, yet the FDA has not approved a new drug to treat the disease since 2003. Our next guest is hoping to change that. David Ricks is th...